WWW.LIVESCIENCE.COM
2-in-1 COVID-flu vaccine looks promising in trial but experts say approval may be delayed
Late-stage trial data suggest that a new COVID-flu vaccine offers good protection against both infections, but experts expect the shot's approval may be delayed.
0 Comentários 0 Compartilhamentos 158 Visualizações